Episode-based payment for cancer care: A proposed pilot for medicare

Health Affairs

Volumn 30, Issue 3, 2011, Pages 500-509

  Bach, Peter B ^a   Mirkin, Joshua N ^a   Luke, Jason J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; PEMETREXED; VINBLASTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; COST CONTROL; DRUG COST; EMERGENCY CARE; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MEDICAL FEE; MEDICARE; MULTIPLE CYCLE TREATMENT; PATIENT CARE; PILOT STUDY; PRACTICE GUIDELINE; REIMBURSEMENT; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COST CONTROL; EPISODE OF CARE; HUMANS; LUNG NEOPLASMS; MEDICARE; PILOT PROJECTS; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 79955510403     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0752     Document Type: Article

References (21)

1. Mechanic RE, Altman SH. Payment reform options: episode payment is a good place to start. Health Aff (Millwood). 2009;28(2):w262-71.
2. De Brantes F, Gosfield AG, Emery D, Rastogi A, D'Andrea G. Sustaining the medical home: how PROMETHEUS payment can revitalize primary care [Internet]. Princeton (NJ): Robert Wood Johnson Foundation; 2009 May [cited 2011 Feb 2]. Available from: http://www.rwjf.org/files/research/prometheusmedicalhomes.pdf.
3. Centers for Medicare and Medicaid Services. End-stage renal disease (ESRD) payment: overview [Internet]. Baltimore (MD): CMS; 2010 Jul [cited 2010 Sep 28]. Available from: http://www.cms.gov/ESRDPayment/.
4. Hackbarth G, Reischauer R, Mutti A. Collective accountability for medical care-toward bundled Medicare payments. N Engl J Med. 2008; 359(1):3-5.
5. Akscin J, Barr TR, Towle EL. Key practice indicators in office-based oncology practices: 2007 report on 2006 data. J Oncol Pract. 2007; 3(4):200-3.
6. To access the Appendix, click on the Appendix link in the box to the right of the article online.
7. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6): 626-33.
8. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced nonsmall-cell lung cancer. N Engl J Med. 2002;346(2):92-8.
9. Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol. 2002;20(21):4285-91.
10. Socinski MA, Bondarenko IN, Karaseva NA, Makhson A, Vynnichenko I, Okamoto I, et al. Results of a randomized, phase III trial of nab-paclitaxel (nab-P) and carboplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC). J Clin Oncol (Annual Meeting Proceedings). 2010; 28(18 suppl):LBA7511.
11. Jacobson M, Earle CC, Price M, Newhouse JP. How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood). 2010; 29(7):1391-9.
12. Scott JA, Wong W, Olson T, Fortner BV. Year one evaluation of regional pay for quality (P4Q) oncology program. J Clin Oncol (Meeting Abstracts). 2010;28(15 suppl):6013.
13. Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, et al. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-smallcell lung cancer in the community setting. J Oncol Pract. 2010;6(1): 12-8.
14. Learn PA, Bach PB. Pem and the cost of multicycle maintenance. J Thorac Oncol. 2010;5(8):1111.
15. Bach PB. Using practice guidelines to assess cancer care quality. J Clin Oncol. 2005;23(36):9041-3.
16. Abraham NS, Gossey JT, Davila JA, Al-Oudat S, Kramer JK. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol. 2006;101(6): 1320-8.
17. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001; 93(11):850-7.
18. Schrag D, Hsieh LJ, Rabbani F, Bach PB, Herr H, Begg CB. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst. 2003;95(8):588-97.
19. Abelson R. Insurers test new cancer pay systems. New York Times. 2010 Oct 20;Sect. B:1.
20. Johnson A. In treating cancer, insurer tries new way to pay docs. Wall Street Journal. 2010 Oct 20;Sect. B:1.
21. United HealthCare [Internet]. Minneapolis (MN): UnitedHealthcare; c2011. Press release, New United-Healthcare cancer care payment model to focus on best treatment practices and better health outcomes; 2010 Oct 20 [cited 2011 Feb 2]. Available from: http://www.uhc.com/news_room/2010_news_release_archive/new_unitedhealthcare_cancer_care_payment_model.htm.